TY - JOUR
T1 - Chronotherapy for the rapid treatment of depression
T2 - A meta-analysis
AU - Humpston, Clara
AU - Benedetti, Francesco
AU - Serfaty, Marc
AU - Markham, Sarah
AU - Hodsoll, John
AU - Young, Allan H.
AU - Veale, David
PY - 2020/1/15
Y1 - 2020/1/15
N2 - Background: Chronotherapy (sleep deprivation, sleep phase shifting and/or the use of bright light) combines non-invasive and non-pharmacological interventions that may act rapidly against depressive symptoms. However, to date no meta-analysis has been conducted to examine their effectiveness. Methods: We carried out meta-analysis of 16 studies (four randomised controlled trials and 12 open-label case series) with between-subject comparisons between experimental and control conditions for RCTs and within-subject comparisons between baseline and follow-up for all studies. Results: Overall chronotherapy was generally superior to other therapies such as psychotherapy, antidepressants, exercise or light therapy alone after 5–7 days. For RCTs, chronotherapy was favoured (Hedge's g = 0.62, 95% CI 0.23–1.01) compared to control treatments such as antidepressants and exercise. 33.0% of patients were responders after 5–7 days in the chronotherapy group and 1.5% of patients in the control condition (OR = 7.58, 95% CI 2.03–28.28). For the case series, large effect sizes were found by 5–7 days (g = 1.78, 95% CI 1.49–2.07). In the case series, 61.6% of patients were classed as responders. Limitations: The number of RCTs included in this meta-analysis was small, and the potential for risk of bias could not be ascertained accurately. One specific limitation is that studies nearly all included in-patients and the results may not be generalisable to out-patients, and nearly all the subjects lacked credibility ratings before receiving treatment. Conclusions: Chronotherapy appears to be effective and well-tolerated in depressed patients. Nevertheless, further clinical and cost effectiveness studies are needed.
AB - Background: Chronotherapy (sleep deprivation, sleep phase shifting and/or the use of bright light) combines non-invasive and non-pharmacological interventions that may act rapidly against depressive symptoms. However, to date no meta-analysis has been conducted to examine their effectiveness. Methods: We carried out meta-analysis of 16 studies (four randomised controlled trials and 12 open-label case series) with between-subject comparisons between experimental and control conditions for RCTs and within-subject comparisons between baseline and follow-up for all studies. Results: Overall chronotherapy was generally superior to other therapies such as psychotherapy, antidepressants, exercise or light therapy alone after 5–7 days. For RCTs, chronotherapy was favoured (Hedge's g = 0.62, 95% CI 0.23–1.01) compared to control treatments such as antidepressants and exercise. 33.0% of patients were responders after 5–7 days in the chronotherapy group and 1.5% of patients in the control condition (OR = 7.58, 95% CI 2.03–28.28). For the case series, large effect sizes were found by 5–7 days (g = 1.78, 95% CI 1.49–2.07). In the case series, 61.6% of patients were classed as responders. Limitations: The number of RCTs included in this meta-analysis was small, and the potential for risk of bias could not be ascertained accurately. One specific limitation is that studies nearly all included in-patients and the results may not be generalisable to out-patients, and nearly all the subjects lacked credibility ratings before receiving treatment. Conclusions: Chronotherapy appears to be effective and well-tolerated in depressed patients. Nevertheless, further clinical and cost effectiveness studies are needed.
KW - chronotherapy
KW - Depression
KW - light therapy
KW - meta-analysis
KW - sleep deprivation
UR - http://www.scopus.com/inward/record.url?scp=85072989622&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2019.09.078
DO - 10.1016/j.jad.2019.09.078
M3 - Review article
AN - SCOPUS:85072989622
SN - 0165-0327
VL - 261
SP - 91
EP - 102
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
M1 - JAD_2019_881_R2
ER -